What disorder could explain anhedonia, neglect of personal hygiene, difficulty dressing, brain fog, anxiety, non‑restorative sleep, and nightmares?

Major Depressive Disorder

Your constellation of symptoms—anhedonia (enjoying nothing), self-care neglect (not showering, difficulty dressing), cognitive impairment (brain fog), anxiety, non-restorative sleep, and nightmares—strongly suggests Major Depressive Disorder (MDD), potentially with comorbid anxiety and nightmare disorder.

Clinical Reasoning

The symptom cluster you describe maps directly onto the diagnostic criteria for MDD:

• Anhedonia is one of the two core diagnostic features of MDD and represents a loss of pleasure or interest in activities 1. This symptom is particularly concerning as it correlates with more severe depressive episodes, increased suicide risk, and poorer treatment response 1, 2.

• Self-care neglect (poor hygiene, difficulty with basic tasks like dressing) reflects the profound motivational deficits and psychomotor changes characteristic of moderate-to-severe depression.

• Cognitive impairment ("brain fog") is a well-recognized feature of MDD, involving impaired concentration, memory problems, and executive dysfunction 3.

• Anxiety co-occurs in the majority of MDD cases. The relationship is bidirectional—anxiety worsens depression and vice versa. Neuroticism appears to be a shared vulnerability factor driving both anxiety and anhedonia 3.

• Non-restorative sleep and nightmares are particularly significant. Sleep disturbances occur in over 80% of patients with depression and anxiety 4. The presence of nightmares specifically suggests either:

  • Nightmare disorder comorbid with MDD (affecting 4% of adults) 5
  • Possible underlying trauma history, as nightmares are strongly associated with PTSD, which shares symptom overlap with your presentation 5

Key Diagnostic Considerations

Look for these specific features to refine the diagnosis:

• Trauma history: Childhood neglect (more than abuse) is strongly associated with anhedonia in depression 6. Emotional neglect shows the strongest correlation with multiple anhedonia subtypes 6.

• Nightmare characteristics: Are they recurrent, dysphoric, well-remembered dreams involving threats? Do they cause sleep avoidance or bedtime anxiety? 5

• Anhedonia subtypes: Does the inability to enjoy things extend to anticipating pleasure (anticipatory anhedonia), experiencing it in the moment (consummatory anhedonia), and social situations (social anhedonia)? 6

• Suicidality: Anhedonia in MDD is linked to increased suicide risk—this requires immediate assessment 1, 2.

Important Clinical Pitfalls

Do not overlook:

• Sleep disorders masquerading as psychiatric symptoms: Obstructive sleep apnea can cause non-restorative sleep, cognitive impairment, and mood symptoms. Consider polysomnography if loud snoring, witnessed apneas, or excessive daytime sleepiness are present 4.

• Medication-induced symptoms: Drugs affecting norepinephrine, serotonin, dopamine, GABA, or acetylcholine can produce nightmares. Withdrawal from REM-suppressing agents can also trigger nightmares 5.

• Persistent anhedonia despite treatment: Neural abnormalities underlying anhedonia (particularly blunted ventral striatum activation) often persist even after successful depression treatment, predicting relapse 2. This means anhedonia requires specific targeting, not just general antidepressant treatment.

Treatment Implications

For the depressive and anhedonic symptoms:

• Standard SSRIs show limited benefit specifically for anhedonia 1. Consider augmentation strategies or alternative approaches targeting reward circuitry.
• Psychotherapy addressing cognitive control deficits may help, as enhanced cognitive control appears protective against anxiety 3.

For the nightmares:

• First-line: Cognitive behavioral therapy, specifically image rehearsal therapy (a modified CBT technique) 5
• Pharmacologic options if nightmares persist: Prazosin is commonly used, particularly if PTSD-related. Other options include trazodone, gabapentin, or topiramate 5
• Avoid: Clonazepam and venlafaxine are not recommended for nightmare disorder 5

For the anxiety and sleep disturbance:

• Addressing anxiety directly will improve sleep quality, as the relationship is bidirectional 4
• Target both conditions concurrently rather than sequentially for optimal outcomes 4

Prognosis

The presence of anhedonia indicates a more severe depressive episode with potentially poorer prognosis 1. However, successful treatment of nightmares improves sleep quality, reduces daytime fatigue, and enhances overall functioning 5. The key is recognizing that anhedonia requires specific attention beyond standard antidepressant treatment, as it represents a distinct neurobiological phenotype with persistent neural abnormalities 2.